Viona Pharmaceuticals recalls nearly 2 dozen lots of Metformin over NDMA concerns
Viona Pharmaceuticals has issued a recall of 23 lots of their 750 mg Metformin Hydrochloride Extended-Release Tablets. The recall was initiated after a routine test found 1 lot to be Out of Specification (OOS) for N-nitrosodimethylamine (NDMA). NDMA is considered a “probable human carcinogen”, meaning it could cause cancer. It’s…
On November 4, 2020, we wrote about how Nostrum Labs joined the list of companies recalling their metformin drugs due to unsafe levels of nitrosamine (NDMA) impurities. Well they’ve now expanded on their just 2 ½ month old recall and are adding their Metformin HCl Extended Release Tablets, USP 750…
Nostrum Labs joins growing list of NDMA metformin recalls
Nostrum Laboratories has issued a voluntary recall of 2 lots of their 750 mg extended release metformin tablets (100 tablet packages) due to elevated levels of the human carcinogen N-nitrosodimethylamine (NDMA). Nostrum did not specify the number of bottles recalled.
Extended-release metformin tablets recalled due to dangerous levels of NDMA
Marksans Pharma Limited, based out of India, is recalling their 500 mg and 750 mg metformin tablets sold under the brand name Time-Cap Labs, Inc. The recalled medication was found to contain dangerous levels of the suspected cancer-causing human carcinogen N-Nitrosodimethylamine (NDMA). These types of medications are used to treat…
RIOMET ER joins list of recalled metformin drugs due to NDMA
It’s September 23, 2020 and another metformin drug has been recalled due to unsafe levels of N-Nitrosodimethylamine (NDMA). Sun Pharmaceutical Industries, Inc. has issued a voluntary recall of their RIOMET ER 500 mg per 5 mL metformin. So far, no illnesses have been reported.
Add Bayshore Pharmaceuticals to the list of recalled diabetes drug companies due to NDMA
Bayshore Pharmaceuticals is the sixth metformin manufacturer to issue a recall due to a possible NDMA contamination. The recalled products were manufactured in Bangladesh in June of 2019, and distributed across the United States. If you've purchased any of the recalled medications, you should return them to your retailer or…
The FDA has officially recalled Zantac as well as other ranitidine drugs
We’ve posted more than a handful of stories over the last year or so about the U.S. Food and Drug Administration’s concerns over the use of ranitidine drugs, but this one is different. After numerous close calls, the FDA has finally recalled Zantac, the prescription and over-the-counter medication used to…
Diabetes drug Metformin tests negative for NDMA, will not be recalled by FDA
With all of the medication recalls lately, it would have been wise for diabetic patients to wonder if their prescribed drug was next. Well the U.S. Food and Drug Administration actually released some good news this week, there are currently “no plans to recall any Metformin products.”
Heartburn medication recalls continue, generic versions of Zantac included
Just when you think it’s safe to resume using your favorite name brand or generic heartburn medication, the U. S. Food and Drug Administration announces a new round of recalls. Once again, generic versions of Zantac are being recalled due to the presence of a “probable human carcinogen”. You shouldn’t…
FDA investigating diabetes drug ‘Metaformin’ over NDMA concerns
Stop us if you’ve heard this one before, there’s a concern over a carcinogen’s possible presence in a widely used medication. The only difference, this one has yet to be recalled, as the U.S. Food and Drug Administration is still investigating.